Mattiuzzo G - Search Results

1

Nanobody-Based Blocking of Binding ELISA for the Detection of Anti-NS1 Zika-Virus-Specific Antibodies in Convalescent Patients.

Delfin-Riela T, Rossotti MA, Mattiuzzo G, Echaides C, González-Sapienza G. Delfin-Riela T, et al. Among authors: mattiuzzo g. Trop Med Infect Dis. 2023 Jan 10;8(1):55. doi: 10.3390/tropicalmed8010055. Trop Med Infect Dis. 2023. PMID: 36668962 Free PMC article.

2

Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay.

Bentley EM, Richardson S, Derveni M, Rijal P, Townsend AR, Heeney JL, Mattiuzzo G, Wright E. Bentley EM, et al. Among authors: mattiuzzo g. Trop Med Infect Dis. 2021 Aug 25;6(3):155. doi: 10.3390/tropicalmed6030155. Trop Med Infect Dis. 2021. PMID: 34449756 Free PMC article.

3

Harmonization of Zika neutralization assays by using the WHO International Standard for anti-Zika virus antibody.

Mattiuzzo G, Knezevic I, Hassall M, Ashall J, Myhill S, Faulkner V, Hockley J, Rigsby P, Wilkinson DE, Page M; collaborative study participants. Mattiuzzo G, et al. NPJ Vaccines. 2019 Oct 14;4:42. doi: 10.1038/s41541-019-0135-3. eCollection 2019. NPJ Vaccines. 2019. PMID: 31632743 Free PMC article.

4

[No title available]

[No authors listed] [No authors listed] PMID: 34521856

5

Passive immunisation of convalescent human anti-Zika plasma protects against challenge with New World Zika virus in cynomolgus macaques.

Berry N, Kempster S, Ham C, Jenkins A, Hall J, Page M, Mattiuzzo G, Adedeji Y, Hewson R, Giles E, Ferguson D, Almond N. Berry N, et al. Among authors: mattiuzzo g. NPJ Vaccines. 2020 Sep 15;5:86. doi: 10.1038/s41541-020-00234-y. eCollection 2020. NPJ Vaccines. 2020. PMID: 33014434 Free PMC article.

6

Comparison of platform technologies for assaying antibody to Ebola virus.

Wilkinson DE, Page M, Mattiuzzo G, Hassall M, Dougall T, Rigsby P, Stone L, Minor P. Wilkinson DE, et al. Among authors: mattiuzzo g. Vaccine. 2017 Mar 1;35(9):1347-1352. doi: 10.1016/j.vaccine.2016.11.083. Epub 2017 Feb 1. Vaccine. 2017. PMID: 28161420 Free PMC article.

7

Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteins.

Leach A, Miller A, Bentley E, Mattiuzzo G, Thomas J, McAndrew C, Van Montfort R, Rabbitts T. Leach A, et al. Among authors: mattiuzzo g. Sci Rep. 2021 May 18;11(1):10475. doi: 10.1038/s41598-021-89887-w. Sci Rep. 2021. PMID: 34006961 Free PMC article.

8

More Than Just Gene Therapy Vectors: Lentiviral Vector Pseudotypes for Serological Investigation.

Toon K, Bentley EM, Mattiuzzo G. Toon K, et al. Among authors: mattiuzzo g. Viruses. 2021 Jan 31;13(2):217. doi: 10.3390/v13020217. Viruses. 2021. PMID: 33572589 Free PMC article. Review.

9

The Role of Reference Materials in the Research and Development of Diagnostic Tools and Treatments for Haemorrhagic Fever Viruses.

Mattiuzzo G, Bentley EM, Page M. Mattiuzzo G, et al. Viruses. 2019 Aug 24;11(9):781. doi: 10.3390/v11090781. Viruses. 2019. PMID: 31450611 Free PMC article. Review.

10

Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins.

Bissett SL, Mattiuzzo G, Draper E, Godi A, Wilkinson DE, Minor P, Page M, Beddows S. Bissett SL, et al. Among authors: mattiuzzo g. Vaccine. 2014 Nov 12;32(48):6548-55. doi: 10.1016/j.vaccine.2014.07.116. Epub 2014 Sep 6. Vaccine. 2014. PMID: 25203446 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters